Evidence map›Paper›PMID 23454694›Full record

Trial reportDiabetes2013

Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.

Bettina Nowotny, Lejla Zahiragic, Dorothea Krog, Peter J Nowotny, Christian Herder, Maren Carstensen, Toru Yoshimura, Julia Szendroedi, Esther Phielix, Peter Schadewaldt and 3 more

Registry-linked trialOpen access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03146286 (Skeletal Muscle Protein Metabolism and Insulin Sensitivity in Overweight Individuals), which is not on this map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03146286 nacompletednot on this mapstarted 2015, after this paper: background citation

Skeletal Muscle Protein Metabolism and Insulin Sensitivity in Overweight Individuals: Effects of Meals With Various Fatty Acid Compositions

TypeinterventionalSponsorUniversity of NottinghamRan2015 to 2015Enrolled8ConditionsInsulin ResistanceArmsSaturated fat, Placebo, Fish Oil
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Bettina NowotnyInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
Lejla Zahiragic
Dorothea Krog
Peter J Nowotny
Christian Herder
Maren Carstensen
Toru Yoshimura
Julia Szendroedi
Esther Phielix
Peter Schadewaldt
Nanette C Schloot
Gerald I Shulman
Michael Roden
Deutsches Diabetes-Zentrum e.V. · DEHeinrich Heine University Düsseldorf · DEDüsseldorf University Hospital · DEHoward Hughes Medical Institute · USYale University · US

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin ResistanceR24DK085638 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2010 to 2014
$6.3M
NMR STUDIES OF GLYCOGEN METABOLISM IN HUMANSR01DK049230 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 1995 to 2014
$5.4M
NIDDK NIH HHS DK-085638NIDDK NIH HHS DK-45735NIDDK NIH HHS DK-49230NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK049230NIDDK NIH HHS R24 DK085638
6 · The paper itself

Abstract

Several mechanisms, such as innate immune responses via Toll-like receptor-4, accumulation of diacylglycerols (DAG)/ceramides, and activation of protein kinase C (PKC), are considered to underlie skeletal muscle insulin resistance. In this study, we examined initial events occurring during the onset of insulin resistance upon oral high-fat loading compared with lipid and low-dose endotoxin infusion. Sixteen lean insulin-sensitive volunteers received intravenous fat (iv fat), oral fat (po fat), intravenous endotoxin (lipopolysaccharide [LPS]), and intravenous glycerol as control. After 6 h, whole-body insulin sensitivity was reduced by iv fat, po fat, and LPS to 60, 67, and 48%, respectively (all P < 0.01), which was due to decreased nonoxidative glucose utilization, while hepatic insulin sensitivity was unaffected. Muscle PKCθ activation increased by 50% after iv and po fat, membrane Di-C18:2 DAG species doubled after iv fat and correlated with PKCθ activation after po fat, whereas ceramides were unchanged. Only after LPS, circulating inflammatory markers (tumor necrosis factor-α, interleukin-6, and interleukin-1 receptor antagonist), their mRNA expression in subcutaneous adipose tissue, and circulating cortisol were elevated. Po fat ingestion rapidly induces insulin resistance by reducing nonoxidative glucose disposal, which associates with PKCθ activation and a rise in distinct myocellular membrane DAG, while endotoxin-induced insulin resistance is exclusively associated with stimulation of inflammatory pathways.

Indexed as

Administration, IntravenousAdministration, OralAdultBlood GlucoseCalorimetry, IndirectFemaleHumansInsulinInsulin ResistanceInterleukin-6LipidsLipopolysaccharidesLiverMaleMuscle, SkeletalTumor Necrosis Factor-alphaBlood GlucoseInsulinInterleukin-6LipidsLipopolysaccharidesTumor Necrosis Factor-alpha

Identifiers

PMID23454694
PMCPMC3712035
OpenAlexW2166568789

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.